Jl. Chen et al., Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats, STROKE, 32(11), 2001, pp. 2682-2688
Background and Purpose-Human umbilical cord blood cells (HUCBC) are rich in
stein and progenitor cells. In this study we tested whether intravenously
infused HUCBC enter brain, survive, differentiate, and improve neurological
functional recovery after stroke in rats. In addition, we tested whether i
schemic brain tissue extract selectively induces chemotaxis of HUCBC in vit
ro.
Methods-Adult male Wistar rats were subjected to transient (2-hour) middle
cerebral artery occlusion (MCAO). Experimental groups were as follows: grou
p 1, MCAO alone (n = 5), group 2, 3 x 10(6) HUCBC injected into tail vein a
t 24 hours after MCAO (n = 6) (animals of groups 1 and 2 were killed at 14
days after MCAO); group 3, MCAO alone (n = 5); group 4, MCAO injected with
PBS at 1 day after stroke (n = 8); and group 5, 3 x 10(6) HUCBC injected in
to tail vein at 7 days after MCAO (n=5). Rats of groups 3, 4, and 5 were ki
lled at 35 days after MCAO. Behavioral tests (rotarod and Modified Neurolog
ical Severity Score [mNSS]) were performed. Immunohistochemical staining wa
s used to identify cells derived from HUCBC. Chemotactic activity of ischem
ia brain tissue extracts toward HUCBC at different time points was evaluate
d in vitro.
Results-Treatment at 24 hours after MCAO with HUCBC significantly improved
functional recovery, as evidenced by the rotarod test and mNSS (P < 0.05).
Treatment at 7 days after MCAO with HUCBC significantly improved function o
nly on the mNSS (P < 0.05). Some HUCBC were reactive for the astrocyte mark
er glial fibrillary acidic protein and the neuronal markers NeuN and microt
ubule-associated protein 2. In vitro, significant HUCBC migration activity
was present at 24 hours after MCAO (P < 0.01) compared with normal brain ti
ssue.
Conclusions-Intravenously administered HUCBC enter brain, survive, migrate,
and improve functional recovery after stroke. HUCBC transplantation may pr
ovide a cell source to treat stroke.